Latest filing published 05 Aug 2024 for Cerevel Therapeutics Holdings, Inc.. Read the official filing
No signal scores available.
All filings by Douglas E. Giordano on record concern Cerevel Therapeutics Holdings, Inc. In total, 3 filings cover trades dated from 7 June 2023 to 1 August 2024.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 5 August 2024 with a transaction in Cerevel Therapeutics Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations